Immune priming has been reported in different plants species, ranging from short-lived annuals, such as thale cress ...

Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients with abnormal protein synthesis are treated to produce a healthy protein.

Cancer Center's lymphoma specialist, Dr. Palomba, provides an in-depth look at how CAR T-cell therapy is evolving to offer hope for more patients battling hematologic malignancies.

Recent advances in the field of immunology suggest that innate immune cells (e.g. dendritic cells, NK cells, phagocytes) are capable of displaying a form of ...

Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) shared new and updated results from its RESET clinical development ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...

TG Therapeutics will use MaxCyte’s technology to advance toward a clinical trial its azer-cel CAR T-cell therapy for ...